https://orcid.org/0000-0002-8250-0054
References
- Bodkin, J. A., & Dunlop, B. W. (2021). Moving on with monoamine oxidase inhibitors. Focus (American Psychiatric Publishing), 19(1), 50–52. https://doi.org/10.1176/appi.focus.20200046
- Figueroa, J. J., Basford, J. R., & Low, P. A. (2010). Preventing and treating orthostatic hypotension: As easy as A, B, C. Cleveland Clinic Journal of Medicine, 77(5), 298–306. https://doi.org/10.3949/ccjm.77a.09118
- Gillman, P. K. (2006). A review of serotonin toxicity data: Implications for the mechanisms of antidepressant drug action. Biological Psychiatry, 59(11), 1046–1051. https://doi.org/10.1016/j.biopsych.2005.11.016
- Van den Eynde, V., Abdelmoemin, W. R., Abraham, M. M., Amsterdam, J. D., Anderson, I. M., Andrade, C., Baker, G. B., Beekman, A. T., Berk, M., Birkenhäger, T. K., Blackwell, B. B., Blier, P., Blom, M. B., Bodkin, A. J., Cattaneo, C. I., Dantz, B., Davidson, J., Dunlop, B. W., Estévez, R. F., … Gillman, P. K. (2022a). The prescriber’s guide to classic MAO-inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. CNS Spectrums, 1–14. https://doi.org/10.1017/S1092852922000906
- Van den Eynde, V., Gillman, P. K., & Blackwell, B. B. (2022b). The prescriber’s guide to the MAOI diet - Thinking through tyramine troubles. Psychopharmacology Bulletin, 52(2), 73–116.